Hisamitsu Pharmaceutical ... (HTSUF)
PNK: HTSUF
· Real-Time Price · USD
32.30
0.00 (0.00%)
At close: Apr 28, 2025, 9:30 AM
0.00% (1D)
| Bid | 27.54 |
| Market Cap | 2.36B |
| Revenue (ttm) | 150.19B |
| Net Income (ttm) | 14.65B |
| EPS (ttm) | 2.05 |
| PE Ratio (ttm) | 15.76 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 32.51 |
| Volume | 1,351 |
| Avg. Volume (20D) | 3 |
| Open | 23.70 |
| Previous Close | 32.30 |
| Day's Range | 23.70 - 32.30 |
| 52-Week Range | 23.70 - 32.30 |
| Beta | 0.40 |
About HTSUF
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic a...
Sector Healthcare
IPO Date Sep 23, 2010
Employees 2,759
Stock Exchange PNK
Ticker Symbol HTSUF
Website https://www.hisamitsu.co.jp